RecruitingNot Applicable

Advancing Suicide Intervention Strategies for Teens During High Risk Periods

United States306 participantsStarted 2022-08-11

Plain-language summary

To inform the effective management of adolescent suicide risk by evaluating promising treatments and developing the evidence-base for interventions that are well suited for widespread adoption, sustained quality, and impact.

Who can participate

Age range11 Years – 17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Provision of signed and dated informed consent form
✓. Youth, aged 11-17
✓. Endorse suicidal ideation and/or behavior
✓. Admitted to acute care (emergency, inpatient medical or inpatient psychiatric) due to suicidality

Exclusion criteria

✕. Presence of psychosis, intellectual disability, autism spectrum disorder, eating disorder with unstable vitals
✕. Limited English proficiency that would interfere with the ability to complete study assessments

What they're measuring

Suicidal events

Timeframe: Suicidal events at 12 months

Trial details

NCT IDNCT05078970

SponsorSeattle Children's Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-01-31

Contact for this trial

Molly Adrian

206-987-7183 molly.adrian@seattlechildrens.org

View on ClinicalTrials.gov More Suicide Attempts trials